Abstract Introduction Pain from chronic pancreatitis (CP) impairs quality of life and demands continuous treatment, whether pharmacological, endoscopic or surgical. Surgical treatment for CP can include solely decompression, resection, or a combination of both. The modified Puestow 1 procedure is an established indication for patients with a dilated pancreatic duct and without the need for parenchyma resection. Methods We report a series of 48 patients who have undergone a Puestow procedure from January 2009 to July 2025 (28 open and 21 robotic). Results This is a retrospective review of a prospectively maintained database. Comparison between groups reveals a shorter overall hospital length of stay and zero readmissions among the robotic group (respectively p = 0.036 and 0.029), as well as no difference in morbidity or operative time when compared to open cases. Conclusion At our high-volume HPB center, robotic Puestow procedures are safe and feasible, with similar complication rates and earlier discharge.
Araujo et al. (Fri,) studied this question.